RUTHERFORD, N.J., Nov. 20, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced.

Options Traders Pile on Sinking Chinese Stock - Schaeffer's Investment Research

07:44am, Wednesday, 20'th Nov 2019

Options traders blast Pinduoduo (PDD) and AT&T (T) stocks, while Cancer Genetics scales the Nasdaq

Mid-Afternoon Market Update: Dow Down 180 Points; Pinduoduo Shares Tumble After Q3 Earnings

12:00am, Wednesday, 20'th Nov 2019

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

Cancer Genetics Stock News

146 Biotechnology Stocks Moving In Thursday's Session

78 Biggest Movers From Yesterday

44 Stocks Moving In Monday's Mid-Day Session

74 Biggest Movers From Friday

55 Stocks Moving In Friday's Mid-Day Session

50 Stocks Moving In Thursday's Mid-Day Session

75 Biggest Movers From Yesterday

Mid-Morning Market Update: Markets Open Lower; Hostess Brands To Buy Voortman Cookies

35 Stocks Moving In Friday's Mid-Day Session

50 Biggest Movers From Friday

66 Biggest Movers From Yesterday

45 Stocks Moving In Thursday's Mid-Day Session

Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update

Options Traders Pile on Sinking Chinese Stock - Schaeffer's Investment Research

Mid-Afternoon Market Update: Dow Down 180 Points; Pinduoduo Shares Tumble After Q3 Earnings

Top Fintech Company